Le Lézard
Classified in: Science and technology, Business
Subject: DIVIDENDS

AlarmForce Announces Declaration of Dividend of $0.045 per Share


TORONTO, ONTARIO--(Marketwired - Oct. 18, 2017) - AlarmForce Industries Inc. (TSX:AF) announces today that the Board of Directors have declared a cash dividend of $0.045 per share payable on November 17, 2017 to all shareholders of record at the close of business on October 31, 2017.

For Canadian resident shareholders, this dividend is designated as an "eligible dividend" for purposes of the enhanced dividend tax credit rules contained in the Income Tax Act (Canada), and any corresponding provincial and territorial tax legislation.

About AlarmForce

AlarmForce provides security alarm monitoring, personal emergency response monitoring, video surveillance and related services to residential and commercial subscribers throughout Canada and in the United States. More information about the Company's products and services can be found at www.alarmforce.com.


These press releases may also interest you

at 20:05
Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, today announced that Cuthbert Simpkins MD, FACS,...

at 19:49
Hamamatsu Photonics K.K. (Hamamatsu City, Japan) is delighted to announce the completion of the acquisition of NKT Photonics A/S. The...

at 19:45
Inocras Inc., a leader in whole genome sequencing (WGS) diagnostics and precision medicine, is proud to present groundbreaking research on radiogenomics and homologous recombination deficiency (HRD) in breast cancer at the American Society of...

at 19:42
Under a newly announced agreement, Discover the World has been chosen to represent South African Airways (SAA) in the strategically important markets of the Nordics (Norway, Sweden, Finland, and Denmark), France, Spain, Switzerland, and Italy...

at 19:35
SterlingBio, a leading US woman-owned Contract Research Organization (CRO), is thrilled to announce that it has secured exclusive global distribution rights for SureClinical's cutting-edge eClinical apps, platform, and cloud, including the management...

at 19:05
Summit Therapeutics Inc. ("Summit," "we," or the "Company") announced that, on May 24, 2024, our partner, Akeso Inc. (Akeso, HKEX Code: 9926.HK), received marketing authorization in China from the National Medical Products Administration (NMPA). The...



News published on and distributed by: